Bill 119 hr 238, also known as the "Artificial Intelligence and Machine Learning Practitioner Act," aims to amend the Federal Food, Drug, and Cosmetic Act to allow artificial intelligence and machine learning technologies to be recognized as practitioners eligible to prescribe drugs. This recognition would be contingent upon authorization by the relevant state and approval, clearance, or authorization by the Food and Drug Administration (FDA).
The bill seeks to clarify the legal status of artificial intelligence and machine learning technologies in the healthcare industry, specifically in the realm of prescribing medication. By allowing these technologies to be considered practitioners, the bill aims to streamline and enhance the prescription process, potentially improving patient care and outcomes.
In addition to addressing the role of artificial intelligence and machine learning technologies in prescribing medication, the bill also includes provisions for other purposes related to healthcare and technology. The overall goal of the bill is to modernize and update existing regulations to better accommodate the use of advanced technologies in the healthcare field.
Overall, Bill 119 hr 238 represents a significant step towards integrating artificial intelligence and machine learning technologies into the healthcare system, with the potential to revolutionize the way medication is prescribed and administered.